Keywords: سیتاگلیپتین; Sitagliptin; Resveratrol; Clear cell; Renal cell carcinoma; Rats;
مقالات ISI سیتاگلیپتین (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: سیتاگلیپتین; Vildagliptin; Drug-induced liver injury; Hypersensitivity; Covalent binding; Nucleophilic trapping agents; ALG; alogliptin; ANG; anagliptin; CRP; C-reactive protein; CYP; cytochrome P450; DILI; drug-induced liver injury; DLST; drug-induced lymphocyte stim
Keywords: سیتاگلیپتین; Sitagliptin; BNP; cGMP; PKG; Cyp D;
Keywords: سیتاگلیپتین; Sitagliptin; Myocardial infarction; Nitirc oxide; Nitric oxide synthase;
Keywords: سیتاگلیپتین; Incretin; GLP-1; Exenatide; DPP-IV; Sitagliptin; Atherosclerosis; Endothelial cell function; Incretin therapy; Vascular inflammation; Cardiovascular diseases;
Keywords: سیتاگلیپتین; Sitagliptin; Pregabalin; PTZ; Oxidative stress; Autophagy; Apoptosis;
Keywords: سیتاگلیپتین; Liver fibrosis; Carbon tetrachloride; Sitagliptin; Silymarin;
Keywords: سیتاگلیپتین; Sitagliptin; Diabetes duration; Blood glucose; β-cell function;
Keywords: سیتاگلیپتین; Acute pancreatitis; Sitagliptin; Taiwan National Health Insurance Program
Keywords: سیتاگلیپتین; Diabetes mellitus; Sitagliptin; Adipocytokines; Phosphatidylcholine 3-kinase
Keywords: سیتاگلیپتین; Anxiety; Cognition; Depression; GLP-1; Liraglutide; Sitagliptin
Keywords: سیتاگلیپتین; Body mass index; HbA1c; Obesity; Sitagliptin; Type 2 diabetes
Keywords: سیتاگلیپتین; Diabetic nephropathy; Sitagliptin; Pioglitazone; CTGF; Metformin; Enalapril
Keywords: سیتاگلیپتین; Aminotransferase; Enzymatic reaction; Sitagliptin; Product inhibition; SHVFOSDHSIFFCF-PCTLFSLLSA-N;
Keywords: سیتاگلیپتین; Sitagliptin; Sulfonylurea; Albuminuria; DPP-4 inhibitors; Nephropathy;
Keywords: سیتاگلیپتین; Type 2 diabetes mellitus; Vildagliptin; Sitagliptin; Fasting plasma glucose; Dipeptidyl peptidase inhibitors
Keywords: سیتاگلیپتین; Dipeptidyl peptidase-4 (DPP-4) inhibitor; Sitagliptin; Creatinine; HbA1c;
Keywords: سیتاگلیپتین; DPP-4 inhibitor; Type 2 diabetes; DPP-8; DPP-9; Sitagliptin; Pyrazolopyrolidine; Omarigliptin; X-ray;
Keywords: سیتاگلیپتین; Streptozotocin; Ischemia/reperfusion; Sitagliptin; Hippocampus; Cytokines; Apoptosis
Keywords: سیتاگلیپتین; Sitagliptin; Dipeptidyl peptidase 4 (DPP-4) inhibitor; Chronic kidney disease; End stage renal disease; Myocardial infarction;
Keywords: سیتاگلیپتین; Type 2 diabetes; DPP-4 inhibitor; Sitagliptin; Fatty liver; Body fat;
Keywords: سیتاگلیپتین; Apoptosis; Rat; Sitagliptin; Type-2 diabetes; Pancreas
Keywords: سیتاگلیپتین; BMI; body mass index; HbA1c; glycated hemoglobin; FPG; fasting plasma glucose; PPG; post-prandial glucose; Durability; Sitagliptin; Glycemic control;
Keywords: سیتاگلیپتین; Sitagliptin; Furosemide; Myocardial injury; Ischemia/reperfusion; Inflammation;
Keywords: سیتاگلیپتین; canagliflozin; composite quality measures; diabetes; quality measures; sitagliptin; T2DM;
Keywords: سیتاگلیپتین; Human; Capillary blood; Metformin; Sitagliptin; Creatinine; Distribution; Blood cells;
Keywords: سیتاگلیپتین; Diabetes mellitus; Sitagliptin; Myocardial remodeling; Cardiac function
Keywords: سیتاگلیپتین; Feline; Sitagliptin; Incretin; Glucagon-like peptide 1; Glucose-dependent insulinotropic polypeptide
Keywords: سیتاگلیپتین; Cardiac function; Genetic Akita mice; Sitagliptin
Keywords: سیتاگلیپتین; Non-alcoholic steatohepatitis (NASH); Sitagliptin; MCD diet; GLP-1; DPP-4 inhibitor;
Keywords: سیتاگلیپتین; DPP4 inhibitor; Sitagliptin; Ischemia/reperfusion; Myocardial injury; Cardiomyocyte apoptosis; Cardiac function;
Keywords: سیتاگلیپتین; Sitagliptin; Glycemic control; Concomitant drugs; Type 2 diabetes
Evaluation of novel TGR5 agonist in combination with Sitagliptin for possible treatment of type 2 diabetes
Keywords: سیتاگلیپتین; TGR5; TGR5 agonist; GPBAR1; GLP1 secretion; Type 2 diabetes; Sitagliptin; DPP-4 inhibitor;
Sitagliptin on carotid intima-media thickness in type 2 diabetes patients receiving primary or secondary prevention of cardiovascular disease: A subgroup analysis of the PROLOGUE study
Keywords: سیتاگلیپتین; Sitagliptin; Intima-media thickness; Type 2 diabetes mellitus; Primary prevention; Secondary prevention;
The dipeptidyl peptidase-4 (DPP-4) inhibitor sitagliptin ameliorates retinal endothelial cell dysfunction triggered by inflammation
Keywords: سیتاگلیپتین; DPP-4 inhibitor; Sitagliptin; Inflammation; Retinal endothelial cells; Endothelial permeability; Angiogenesis; Migration;
Worsening Heart Failure During the Use of DPP-4 Inhibitors
Keywords: سیتاگلیپتین; diabetes; DPP-4 inhibitors; heart failure risk; saxagliptin; sitagliptin; AMP; adenosine monophosphate; DPP; dipeptidyl peptidase; GLP; glucagon-like peptide; SDF; stromal cell-derived factor; SGLT2; sodium-glucose transporter 2;
Sitagliptin attenuates myocardial apoptosis via activating LKB-1/AMPK/Akt pathway and suppressing the activity of GSK-3β and p38α/MAPK in a rat model of diabetic cardiomyopathy
Keywords: سیتاگلیپتین; Diabetic cardiomyopathy; Sitagliptin; Akt; Glycogen synthase kinase-3β; AMPK; p38MAPK;
Investigation of in vitro genotoxic effects of an anti-diabetic drug sitagliptin
Keywords: سیتاگلیپتین; Sitagliptin; Antidiabetic drug; Human lymphocytes; Genotoxicity; T2DM; Type 2 diabetes mellitus; DPP-4; dipeptidyl peptidase-4; GLP-1; incretin hormones glucagon-like peptide-1; GIP; glucose-dependent insulinotropic polypeptide; CAs; chromosome aberration
Sitagliptin attenuates intestinal ischemia/reperfusion injury via cAMP/PKA, PI3K/Akt pathway in a glucagon-like peptide 1 receptor-dependent manner
Keywords: سیتاگلیپتین; Sitagliptin; Intestinal ischemia/reperfusion; GLP-1 receptor; cAMP/PKA; PI3K/Akt;
The persistent inhibitory properties of saxagliptin on renal dipeptidyl peptidase-4: Studies with HK-2 cells in vitro and normal rats in vivo
Keywords: سیتاگلیپتین; Dipeptidyl peptidase-4 inhibitor; Saxagliptin; Sitagliptin; Renal dipeptidyl peptidase-4; Renal tubular cells;
Glycyrrhizic acid increases glucagon like peptide-1 secretion via TGR5 activation in type 1-like diabetic rats
Keywords: سیتاگلیپتین; Glycyrrhizic acid; GLP-1; TGR5; Triamterene; Sitagliptin;
Sitagliptin but not alpha glucosidase inhibitor reduced the serum soluble CD163, a marker for activated macrophage, in individuals with type 2 diabetes mellitus
Keywords: سیتاگلیپتین; Sitagliptin; α Glucosidase inhibitor; Macrophage; Soluble CD163; Chronic inflammation;
Hindbrain DPP-IV inhibition improves glycemic control and promotes negative energy balance
Keywords: سیتاگلیپتین; Sitagliptin; Januvia; Blood glucose; Body weight; Food intake;
Efficacy and Safety of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin on Atherosclerosis, β-Cell Function, and Glycemic Control in Japanese Patients with Type 2 Diabetes Mellitus Who are Treatment Naïve or Poorly Responsive to Antidiabetes Agents: A M
Keywords: سیتاگلیپتین; pentraxin-3; dipeptidyl peptidase-4 inhibitor; sitagliptin; proinsulin/insulin ratio;
CB-1R and GLP-1R gene expressions and oxidative stress in the liver of diabetic rats treated with sitagliptin
Keywords: سیتاگلیپتین; Sitagliptin; Diabetes; Cannabinoid 1 receptor; Glucagon like peptide 1 receptor; Oxidative stress;
Apigenin attenuates hippocampal oxidative events, inflammation and pathological alterations in rats fed high fat, fructose diet
Keywords: سیتاگلیپتین; High calorie diet; Hippocampus; Oxidative stress; Inflammation; Apigenin; Sitagliptin; HFFD; high fat-high fructose diet; API; apigenin; STG; sitagliptin; IKKβ; inhibitor of kappa B kinase beta; NF-κB; nuclear factor kappa B; JNK; c-Jun NH2 terminal kin
HbA1c Outcomes in Patients Treated With Canagliflozin Versus Sitagliptin in US Health Plans
Keywords: سیتاگلیپتین; canagliflozin; diabetes; glycosylated hemoglobin; HbA1c; sitagliptin;
Potential involvement of JNK1 repression in the hepatic effect of sitagliptin and metformin in rats subjected to high fat diet and chronic mild distress
Keywords: سیتاگلیپتین; Behavior; Chronic restraint stress; Depression; JNK; Metformin; NASH; Rat; Sitagliptin;
The effects of sitagliptin, a DPP-4 inhibitor, on cognitive functions in elderly diabetic patients with or without Alzheimer's disease
Keywords: سیتاگلیپتین; Sitagliptin; Cognitive function; Alzheimer disease; Dementia; Elderly;
Combined therapy with sitagliptin plus granulocyte-colony stimulating factor in patients with acute myocardial infarction - Long-term results of the SITAGRAMI trial
Keywords: سیتاگلیپتین; Acute myocardial infarction; Clinical studies; Granulocyte-colony stimulating factor; Sitagliptin; Dipeptidylpeptidase IV; Progenitor cell therapy;